Search Results - "Hill, Colin S"
-
1
A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial
Published in Radiation oncology (London, England) (28-10-2022)“…Localized pancreatic adenocarcinoma carries a poor prognosis even after aggressive therapy. Up to 40% of patients may develop locoregional disease as the first…”
Get full text
Journal Article -
2
Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
Published in Radiation oncology (London, England) (24-12-2021)“…The purpose of this study was to determine if vertebral body and splenic dosimetry was associated with the development of lymphopenia in patients with…”
Get full text
Journal Article -
3
Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
Published in Radiation oncology (London, England) (19-03-2021)“…Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy…”
Get full text
Journal Article -
4
Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature
Published in Current oncology (Toronto) (11-01-2022)“…To report on clinical outcomes and toxicity in older (age ≥ 70 years) patients with localized pancreatic cancer treated with upfront chemotherapy followed by…”
Get full text
Journal Article -
5
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Published in Radiation oncology journal (01-12-2021)“…The purpose of this study was to determine if somatic mutations are associated with clinical and pathologic outcomes in patients with borderline resectable…”
Get full text
Journal Article -
6
Identification of the activator-binding residues in the second cysteine-rich regulatory domain of protein kinase Cθ (PKCθ)
Published in Biochemical journal (01-04-2013)“…PKC (protein kinase C) θ is predominantly expressed in T-cells and is critically involved in immunity. Design of PKCθ-selective molecules to manage autoimmune…”
Get more information
Journal Article -
7
Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP
Published in Bioorganic & medicinal chemistry (15-06-2014)“…[Display omitted] The development of selective agents capable of discriminating between protein kinase C (PKC) isoforms and other diacylglycerol…”
Get full text
Journal Article -
8
The Current Role of Radiation in Pancreatic Cancer and Future Directions
Published in Clinical colorectal cancer (01-03-2023)“…Survival outcomes for localized pancreatic adenocarcinoma remains poor. Multimodality therapeutic regimens are critical to maximizing survival outcomes for…”
Get full text
Journal Article -
9
Phase I Study of Adjuvant Allogeneic GM-CSF-Transduced Pancreatic Tumor Cell Vaccine, Low Dose Cyclophosphamide, and SBRT followed by FFX in High-Risk Resected Pancreatic Ductal Adenocarcinoma
Published in International journal of radiation oncology, biology, physics (13-11-2024)“…Local and distant progression remain common following resection of resectable pancreatic ductal adenocarcinoma (PDAC) despite adjuvant multiagent chemotherapy…”
Get full text
Journal Article -
10
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Published in Annals of surgical oncology (01-04-2022)“…Background Patients with borderline resectable pancreatic cancer (BRPC) or locally advanced pancreatic cancer (LAPC) are at high risk of margin-positive…”
Get full text
Journal Article -
11
Effectiveness of the nutrition referral system in a multidisciplinary pancreatic cancer clinic
Published in Supportive care in cancer (01-06-2023)“…Purpose Proactive nutrition screening and intervention is associated with improved outcomes for patients with pancreatic adenocarcinoma (PDAC). To better…”
Get full text
Journal Article -
12
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer
Published in Journal of gastrointestinal oncology (01-02-2022)“…The purpose of this study is to report on the prognostic role of pre- and post-stereotactic body radiation therapy (SBRT) neutrophil-to-lymphocyte ratio (NLR)…”
Get full text
Journal Article -
13
Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial
Published in Practical Radiation Oncology (01-11-2022)“…In a prospective multicenter study, gemcitabine monotherapy followed by stereotactic body radiation therapy (SBRT) was well tolerated with outcomes comparable…”
Get full text
Journal Article -
14
Location, Location, Location: What Should be Targeted Beyond Gross Disease for Localized Pancreatic Ductal Adenocarcinoma? Proposal of a Standardized Clinical Tumor Volume for Pancreatic Ductal Adenocarcinoma of the Head: The “Triangle Volume”
Published in Practical Radiation Oncology (01-05-2022)“…In patients with borderline resectable or locally advanced pancreatic adenocarcinoma (BRPC/LAPC), local failure rates after resection remain significant, even…”
Get full text
Journal Article -
15
Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection
Published in Journal of gastrointestinal oncology (01-06-2022)“…To report on a cohort of radiation-naïve patients with pancreatic cancer who developed isolated local recurrence following surgical resection and were…”
Get full text
Journal Article -
16
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Published in Radiation oncology journal (01-06-2022)“…To investigate the role of pre- and post-stereotactic body radiation therapy (SBRT) neutrophil-to-lymphocyte ratio (NLR) in patients with localized pancreatic…”
Get full text
Journal Article -
17
Design and synthesis of protein kinase C epsilon selective diacylglycerol lactones (DAG-lactones)
Published in European journal of medicinal chemistry (27-01-2015)“…DAG-lactones afford a synthetically accessible, high affinity platform for probing structure activity relationships at the C1 regulatory domain of protein…”
Get full text
Journal Article -
18
Charge Density Influences C1 Domain Ligand Affinity and Membrane Interactions
Published in Chembiochem : a European journal of chemical biology (26-05-2014)“…The C1 domain, which represents the recognition motif on protein kinase C for the lipophilic second messenger diacylglycerol and its ultrapotent analogues, the…”
Get full text
Journal Article -
19